Treatment of Myelodysplastic syndrome with azacitidine and erythropoietin

被引：0
|
作者：
Limaye, Sewanti [1 ]
Lipshitz, Jay [1 ]
Dulala, Renuka [1 ]
Patel, Dilip [1 ]
机构：
[1] Long Isl Jewish Med Ctr, New Hyde Pk, NY USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4627
引用
收藏
页码：230B / 230B
页数：1
相关论文
共 50 条
  • [41] Successful treatment by azacitidine therapy of intestinal Behcet's disease associated with myelodysplastic syndrome
    Tanaka, Hiroaki
    Shimizu, Naomi
    Tougasaki, Emi
    Kawajiri, Chika
    Hashimoto, Shinichiro
    Takeda, Yusuke
    Sakai, Shio
    Takeuchi, Masahiro
    Ohwada, Chikako
    Sakaida, Emiko
    Takagi, Toshiyuki
    Nakaseko, Chiaki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (04) : 520 - 524
  • [42] DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
    Huong Thi Thanh Tran
    Kim, Hee Nam
    Lee, Il-Kwon
    Kim, Yeo-Kyeoung
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Hyeoung-Joon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 207 - 213
  • [43] Azacitidine Treatment of Lenalidomide-Resistant Myelodysplastic Syndrome with Deletion 5q
    Komrokji, Rami S.
    Al Ali, Najla H.
    Padron, Eric
    Lancet, Jeffrey E.
    List, Alan F.
    BLOOD, 2011, 118 (21) : 1195 - 1195
  • [44] Treatment of intermediate and high risk myelodysplastic syndrome patients with azacitidine. The Hellenic experience
    Pappa, V.
    Papageorgiou, S.
    Tsirigotis, P.
    Dervenoulas, J.
    Girkas, K.
    Papageorgiou, E.
    Poulakidas, H.
    Papadaki, E.
    Galanopoulos, A.
    Vervessou, E.
    Panayotidis, P.
    Zomas, A.
    Symeonidis, A.
    Economopoulos, T.
    LEUKEMIA RESEARCH, 2009, 33 : S134 - S135
  • [45] Outcome of acute myeloid leukaemia following myelodysplastic syndrome after azacitidine treatment failure
    Prebet, Thomas
    Gore, Steven D.
    Thepot, Sylvain
    Esterni, Benjamin
    Quesnel, Bruno
    Rauzy, Odile Beyne
    Dreyfus, Francois
    Gardin, Claude
    Fenaux, Pierre
    Vey, Norbert
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (06) : 764 - 766
  • [46] Clinical Experience with Azacitidine In Secondary Myelodysplastic Syndrome In Spain
    Garcia, Regina
    Sanz, Guillermo F.
    de Miguel Llorente, Dunia
    Nomdedeu, Benet
    Mar Romero, Ma
    Bernal, Teresa
    Besalduch, Juan
    Amutio, Elena
    Brunet, Salut
    BLOOD, 2010, 116 (21) : 772 - 772
  • [47] An Unexpected Innocent Complication Associated with Azacitidine Treatment of Myelodysplastic Syndrome: Erythema Annulare Centrifugum
    Erkek, Esra Turan
    Besisik, Sevgi Kalayoglu
    TURKISH JOURNAL OF HEMATOLOGY, 2016, 33 (01) : 81 - 82
  • [48] Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment
    Georg Feldmann
    Peter Brossart
    Marie von Lilienfeld-Toal
    Annals of Hematology, 2013, 92 : 1577 - 1579
  • [49] P53 EXPRESSION IN PATIENTS WITH MYELODYSPLASTIC SYNDROME AT DIAGNOSIS AND FOLLOWING TREATMENT WITH AZACITIDINE
    Maung, S.
    Strahan, N.
    Desmond, R.
    McHugh, J.
    Burke, C.
    O'Loughlin, J.
    Jeffers, M.
    Enright, H.
    HAEMATOLOGICA, 2015, 100 : 491 - 491
  • [50] Transient and fully reversible leukocytosis in a myelodysplastic syndrome patient upon initiation of azacitidine treatment
    Feldmann, Georg
    Brossart, Peter
    von Lilienfeld-Toal, Marie
    ANNALS OF HEMATOLOGY, 2013, 92 (11) : 1577 - 1579
12345